In this article, we will take a look at some of the best stocks to buy now according to AI.

If there’s one thing that is everywhere, it’s AI. From educational institutions and corporations to government organizations and now the stock market, AI has transformed the way the world works.

Many people believe that real art is in knowing the use of AI “responsibly,” and this is why most companies are mastering responsible AI governance while embracing its potential. According to a report by eToro, one in ten retail investors utilizes AI tools, including ChatGPT, to pick stocks and alter investments.

As eToro Global Markets Strategist, Ben Laidler, cites,

“Consumer AI tools are seeing the fastest growth rates of any technology in history, and it’s no surprise that early adopters are starting to use them for investing.”

Our Methodology

In this article, we have selected stocks that were featured in Insider Monkey’s article “15 Stocks That Will Make You Rich in 5 Years According to ChatGPT.” We have ranked these stocks based on the returns they have delivered since the article’s publication in December 2023, arranged from highest to lowest.

Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 373.4% since May 2014, beating its benchmark by 218 percentage points (see more details here).

11. Adobe Inc. (NASDAQ:ADBE)

Returns as of August 19, 2025: -40.1%

Wedbush has removed Adobe Inc. (NASDAQ:ADBE) from its IVES AI 30 list, which is a group of 30 tech companies that Daniel Ives believes will define the future of AI in the years ahead.

Among the biggest fears Adobe Inc. (NASDAQ:ADBE) faces is the rise of generative AI. One wonders: why should I pay a subscription fee to creative professionals when there are cheaper or even free alternatives available for creating and designing? However, there’s certainly more to the company, which is why many analysts recommend buying the stock.

The company’s transition from tools to systems is what’s making it attractive. AI monetization, platform lock-in, and expanding margins, along with Firefly Video Model and premium AI tiers, will position Adobe Inc. (NASDAQ:ADBE) well in the market.

Adobe Inc. (NASDAQ:ADBE) is a California-based technology company that operates through three segments: Digital Media, Digital Experience, and Publishing and Advertising. Founded in 1982, the company is committed to empowering everyone, everywhere.

10. PayPal Holdings, Inc. (NASDAQ:PYPL)

Returns as of August 19, 2025: 12.55%

Dimensional Fund Advisors LP increased its stake in PayPal Holdings, Inc. (NASDAQ:PYPL) by 14% during the first quarter. Following the purchase of 491,997 shares, the firm owns 4,012,795 shares of the company’s stock, valued at $261,792,000.

PayPal Holdings, Inc. (NASDAQ:PYPL) is undergoing a strategic shift with the management now focusing on high-margin segments and improved execution. By 2027, the company is anticipated to unlock $4.4 billion to $8.8 billion in incremental TPV, which means $300 million to $500 million in new revenue generation.

In this trembling market, investors keep PayPal Holdings, Inc. (NASDAQ:PYPL) as a top pick due to its profitable growth, aggressive share repurchases, and a robust balance sheet. This is supported by the management’s emphasis on branded processing and accelerating growth in Venmo.

PayPal Holdings, Inc. (NASDAQ:PYPL) is a California-based company that operates as a technology platform facilitating digital payments for both consumers and merchants. Founded in 1998, the company is committed to democratizing financial services.

9. Johnson & Johnson (NYSE:JNJ)

Returns as of August 19, 2025: 14.05%

According to the recent disclosure with the Securities and Exchange Commission (SEC), Sector Gamma AS has increased its position in Johnson & Johnson (NYSE:JNJ) by 25.6% in the first quarter. The firm now owns 98,000 shares of the company’s stock, including the addition of 20,000 shares. With a stake worth $16.25 million, the consumer healthcare giant ranks as Sector Gamma AS’s sixth-largest holding.

Many analysts believe that the story of Johnson & Johnson (NYSE:JNJ) is far from over. Just recently, the company’s revenue and EPS surpassed Wall Street’s expectations by a significant margin. If its “outdated” superstar Stelara is weakening, the oncology franchise is gaining momentum. So, much of the decline has been more than compensated for. And that’s what is so special about the company.

Much of the hope surrounds Erleada, which is becoming the definitive standard in prostate cancer treatment, achieving $908 million in sales. This 17.8% quarter-over-quarter increase signals one thing: it’s just getting started.

Johnson & Johnson (NYSE:JNJ), headquartered in New Jersey, offers healthcare products worldwide. Founded in 1886, the company operates in two main segments: Innovative Medicine and MedTech. With a commitment to care for the world, the healthcare powerhouse distributes its products to wholesalers, hospitals, and retailers.